Salem Partners, LLC - Investment Banking and Wealth Management
  • Home
  • About
  • Investment Banking
    • Valuation Services
    • Media & Entertainment
    • Healthcare & Life Sciences
    • Real Estate
    • Specialty & Lender Finance
    • Transactions
  • Wealth Management
    • Portfolio Log In
  • Real Estate Development
  • Professionals
  • News
  • Contact

Femasys Secures Term Loan Facility from Silicon Valley Bank 

7/9/2015

 
Picture
ATLANTA, July 9, 2015 /PRNewswire/ -- Femasys Inc., a developer of innovative medical devices for the women's healthcare market, announced today that it has secured a term loan facility from Silicon Valley Bank.  Under the loan facility, the company ... (read more)


Neos Therapeutics files for an IPO with $69 million value

6/23/2015

 
Picture
After bringing in one of the top venture capital investments during first quarter 2015, Neos Therapeutics has filed for an initial public offering.  The Grand Prairie-based company, which develops medication for Attention Deficit/Hyperactivity Disorder, filed Friday to trade on the Nasdaq under ticker symbol NEOS. It has a place holder value... (read more)


Cynvenio Biosystems Announces $25.5 Million Series B Financing

6/17/2015

 
Picture
LOS ANGELES--(BUSINESS WIRE)--Cynvenio Biosystems, Inc., the pioneer in LiquidBiopsy technology for the genomic analysis of tumor cells from whole blood in support of cancer precision medicine strategies, announced today the completion... (read more)

Robert Redford's Sundance Cinemas looks for a buyer

6/10/2015

 
Picture
LOS ANGELES, Calif., June 10, 2015 (LA TIMES) -- Robert Redford's Sundance Cinemas is putting itself up for sale.  Sundance Cinemas said in a statement that it has hired the investment bank Salem Partners to find a buyer for the small L.A.-based theater chain.  Sundance Cinemas is part of several entities overseen by Redford... (read more)


ZS Pharma Submits New Drug Application to U.S. Food and Drug Administration for ZS-9 for the Treatment of Hyperkalemia

5/26/2015

 
Picture
REDWOOD CITY, Calif., May 26, 2015 (GLOBE NEWSWIRE) -- ZS Pharma, Inc. (Nasdaq:ZSPH), a biopharmaceutical company focused on the development and commercialization of highly selective, non-absorbed drugs to treat renal, cardiovascular, liver and metabolic disorders, today announced that it has submitted a New Drug Application (NDA) to... (read more)

Femasys Completes $10.2 Million Series B Financing Round

4/29/2015

 
Picture
Atlanta, GA -April 29, 2015 - Femasys Inc., a developer of innovative medical devices for the women's healthcare market has raised a $10.2 million financing round. The investor group was led by Legacy Capital Partners and Mario Family Partners, the family offices of... (read more)

Salem Partners Advises PAVe (ProPark & Parkit Enterprises) in $500 million Parking Acquisitions Joint-Venture

4/22/2015

 
Picture
LOS ANGELES, CA, April 22, 2015 -- Salem Partners is pleased to announce the completion of a $500 million programmatic joint-venture in the real estate / parking sector for its client, Parking Acquisition Venture (PAVe). PAVe is a partnership between Propark America and Parkit and... (read more)

IF YOU CAN’T BEAT THEM, HIRE THEM

4/21/2015

 
Picture
Emblematic of the state of the financial world, former Federal Reserve Chairman Ben Bernanke is taking an advisory role with Citadel, the $25 billion hedge fund based in Chicago. Making less of a splash but certainly worth pointing out, Bernanke follows...(read more)

Salem Partners Advises Process Fab Inc. in Sale to Burtek Enterprises

12/10/2014

 
Picture
CHESTERFIELD, Mich., Dec. 10, 2014 /PRNewswire/ -- The Burtek Group ("Burtek") has acquired Process Fab, Inc. ("PFI") based inSanta Fe Springs, CA. The combination of Votaw Precision Technologies, Inc. ("Votaw") and PFI under the Burtek portfolio, brings together two of the best spaceflight and aerospace suppliers in the industry and creates a... (read more)

Salem Partners Advises Merlin RAMCo in Sale to Trive Capital

10/15/2014

 
Picture
DALLAS, Texas, JACKSONVILLE, Florida, and SAVANNAH, Tennessee, October 15, 2014 - Trive Capital ("Trive"), the Dallas-based private equity firm, is proud to announce its investments in Merlin RAMCo, LLC ("Merlin") and ISR Group LLC ("ISR"). Headquartered in Jacksonville, Florida, Merlin is a leading... (read more)

Salem Partners Advises Impresa Aerospace in Sale to Twin Haven Capital

10/7/2014

 
Picture
Gardena, CA (October 7, 2014) Impresa Aerospace, a leading supplier to the commercial and military aerospace industries, announced today that it has been acquired by a private equity fund managed by Twin Haven... (read more)

Millennium Entertainment Brass To Acquire Company's Distribution & Catalog Biz

8/19/2014

 
Picture
Millennium Entertainment, the distribution arm of Avi Lerner's Nu Image, officially went up for sale back in April 2013. Now there is a deal from within after entities like Luc Besson's EuropaCorp kicked the tires: The Millennium Entertainment management team led by CEO Bill Lee and private investment firm Virgo Investment Group are... (read more)

Salem Partners Advises Dynamic Paint Solutions in Sale to Valence Surface Technologies

8/14/2014

 
Picture
Private equity-backed Valence Technologies has acquired Pride Plating, Dynamic Paint Solutions and Coastline Metal Finishing.  Pride, headquartered in Tulsa, Oklahoma, provides processing and sub-assembly for large aluminum and titanium structures, specifically for aircrafts... (read more)


Former Cantor Real Estate I-Banker Targeting Private Capital at Salem Partners

8/12/2014

 
Picture
Salem Partners LLC, a boutique investment bank and wealth management firm, announced the addition of real estate veterans Jeff Barcy and Sean Lenz to its team in April. The pair hailed from Cantor Fitzgerald & Co., where Barcy ran the national real estate investment banking practice. Barcy recently spoke with SNL about his new position and his plans to focus on raising private... (read more)

ZS Pharma Announces Allowance of Two U.S. Patent Applications for ZS-9

7/8/2014

 
Picture
COPPELL, Texas, July 8, 2014 (GLOBE NEWSWIRE) -- ZS Pharma, a biopharmaceutical company developing novel treatments for kidney, cardiovascular, liver and metabolic disorders, announced today that it has received Notices of Allowance from the U.S. Patent and Trademark...(read more) 

ZS Pharma Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Over-Allotment Option

6/24/2014

 
Picture
COPPELL, Texas--(BUSINESS WIRE)--ZS Pharma, Inc., a biopharmaceutical company developing novel treatments for kidney, cardiovascular, liver and metabolic disorders, today announced the closing of its initial public offering of 6,836,111 shares of common stock at a public offering price of $18.00 per share. This includes the exercise in...(read more)

ZS Pharma, Inc. Announces Pricing of Initial Public Offering

6/17/2014

 
Picture
COPPELL, Texas--(BUSINESS WIRE)--ZS Pharma, Inc., a biopharmaceutical company developing novel treatments for kidney, cardiovascular, liver and metabolic disorders, today announced the pricing of its initial public offering of 5,944,444 shares of its common stock at a price to the public of $18.00 per share. The shares are expected to begin... (read more)

Healthcare & Life Sciences Outlook 2014

6/4/2014

 
Picture
In corporate development there are few investable and actionable certainties. Here today, in 2014, we face one of the most significant certainties that operators and investors will encounter for decades to come – the comprehensive redesign of the health services and life sciences industries.

In this healthcare & life sciences report, we highlight today’s growth areas and opportunities, with an aim to provide insight into current trends and business drivers. This report explores the shifts taking place within the US healthcare industry to enable stakeholders to formulate better decisions and strategies. Our overarching goal is to ensure that providers, investors and corporate development professionals remain well-placed to realize healthy returns. (read more)


Neos Therapeutics announces $20 million loan facility and updated total of $18 million for its additional Series C financing

4/23/2014

 
Picture
DALLAS/FORT WORTH, Texas, Apr 23, 2014 (BUSINESS WIRE) -- Neos Therapeutics, Inc. (“Neos” or “the Company”),a highly differentiated oral drug delivery company with an exciting portfolio of proprietary technologies and a late-stage pipeline of innovative controlled release (CR) products for ADHD, announced today that it has entered into a $20 million loan facility with Hercules... (read more)

Salem Partners Expands Real Estate Investment Banking Practice with Key Hires

4/1/2014

 
Picture
LOS ANGELES, CA - April 2014 - Salem Partners, a Los Angeles-based investment bank and wealth management firm, is pleased to announce the hiring of real estate industry veterans Jeff Barcy and Sean Lenz. The new team will focus on private capital raising for top real estate operators in the U.S. This effort will include joint venture equity and private debt placements, sourced from the team's deep relationships with... (read more)

Salem Partners advises Coast Plating and Chrome Plus International in partnership with Trive Capital

3/7/2014

 
Picture
Dallas private equity firm Trive Capital has combined Coast Plating Inc. and Chrome Plus International Inc. to form Valence Surface Technologies.  Valence is an independently owned aerospace and defense metal processing company. Terms of the deal were not disclosed.  Coast Plating, headquartered in Los Angeles., provides metal processing and finishing... (read more)


ZS Pharma completes $55 million financing to advance its Novel investigational treatment for hyperkalemia

3/5/2014

 
Picture
COPPELL, Texas--(BUSINESS WIRE)--ZS Pharma, a specialty pharmaceutical company developing novel treatments for kidney, cardiovascular, and liver disorders, today announced that it has completed a $55 million Series D financing. The investor syndicate was led by Novo A/S and included new investors RA Capital, Adage Capital, Sofinnova Ventures, and... (read more)

Neos Therapeutics completes $15.5 million additional Series C financing

3/4/2014

 
Picture
DALLAS/FORT WORTH, Texas--(BUSINESS WIRE)--Neos Therapeutics, Inc. (“Neos” or “the Company”), a highly differentiated oral drug delivery company with an exciting portfolio of proprietary technologies and a late-stage pipeline of innovative controlled release (CR) products for ADHD, announced today that it has completed an oversubscribed round of private financing, raising a total... (read more)

Salem Partners Vice President Ryan Murphy discusses A&D metal processing in November edition of Products Finishing Magazine

11/1/2013

 
Picture
As Boeing and Airbus demand more finishing capacity, the challenges faced by owners of finishing businesses are pressing, as both customers and regulatory agencies amp up demands for management attention and resources.  The surface finishing industry is experiencing a business environment unlike anything seen in the last... (read more)


Salem Partners advises Ascent Aviation in sale to LongueVue Capital Partners

10/18/2013

 
Picture
Los Angeles, CA (PRWEB) October 18, 2013 -- Victory Park Capital announced the sale of its portfolio company, Ascent Aviation Services Corp (“Ascent” or the “Company”), to LongueVue Capital Partners II, LP (“LVC”), a New Orleans-based private equity firm. Salem Partners, a Los Angeles-based investment bank and wealth management firm, advised VPC and Ascent on the transaction. The terms... (read more) 


<<Previous
Forward>>

    News

    All
    Aerospace & Defense
    Healthcare & Life Sciences
    Investment Banking
    Media & Entertainment
    Real Estate
    Specialty & Lender Finance
    Wealth Management

    Archives

    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    February 2021
    December 2020
    August 2020
    November 2019
    August 2019
    July 2019
    December 2018
    November 2018
    September 2018
    July 2018
    June 2018
    May 2018
    April 2018
    January 2018
    November 2017
    July 2017
    February 2017
    December 2016
    November 2016
    October 2016
    July 2016
    December 2015
    November 2015
    October 2015
    July 2015
    June 2015
    May 2015
    April 2015
    December 2014
    October 2014
    August 2014
    July 2014
    June 2014
    April 2014
    March 2014
    November 2013
    October 2013
    February 2013
    December 2012
    October 2012
    February 2012
    January 2012
    December 2011
    September 2011
    August 2011
    June 2011
    January 2010
    December 2009
    November 2009
    August 2009
    June 2009
    February 2009
    September 2008
    August 2008
    July 2008
    June 2008
    May 2008
    April 2008
    February 2008
    December 2007
    July 2007
    May 2007
    February 2007
    January 2007
    December 2006
    November 2006
    October 2006

    RSS Feed

© 2016 by Salem Partners LLC - All Rights Reserved. Member FINRA/SIPC.
11111 Santa Monica Blvd. Suite 2250, Los Angeles, CA 90025